The improvement of modified Si-Miao granule on hepatic insulin resistance and glycogen synthesis in type 2 diabetes mellitus involves the inhibition of TNF-α/JNK1/IRS-2 pathway: network pharmacology, molecular docking, and experimental validation

• Auteurs principaux: Zebiao Cao (Auteur), Xianzhe Wang (Auteur), Zhili Zeng (Auteur), Zhaojun Yang (Auteur), Yuping Lin (Auteur), Lu Sun (Auteur), Qiyun Lu (Auteur), Guanjie Fan (Auteur)
• Format: Livre
• Publié: BMC, 2024-09-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Abstract Background Modified Si-Miao granule (mSMG), a traditional Chinese medicine, is beneficial for T2DM and insulin resistance (IR), but the underlying mechanism remains unknown. Methods Using network pharmacology, we screened the compounds of mSMG and identified its targets and pathway on hepat...